Literature DB >> 10689019

Evaluation of a large cohort of men presenting for a screening semen analysis.

B D Acacio1, T Gottfried, R Israel, R Z Sokol.   

Abstract

OBJECTIVE: To determine: [1] what percentage of men in an infertile relationship will have a semen abnormality, [2] the average value for each semen parameter in this group of men, [3] the distribution of abnormal semen parameters in this group, and [4] if our data support the hypothesis that sperm concentration is declining.
DESIGN: Retrospective cohort study.
SETTING: County hospital university-based infertility clinic. PATIENT(S): Male partners of women presenting for an infertility evaluation. INTERVENTION(S): Semen specimens were collected after 2-5 days of abstinence. MAIN OUTCOME MEASURE(S): Sperm concentration, motility, and morphology. RESULT(S): Fifty-two percent of samples had at least one sperm abnormality based on World Health Organization criteria. Fifty-one percent had an abnormality in sperm motility, 18% in sperm concentration, and 14% in sperm morphology. Four percent of the patients were azoospermic. CONCLUSION(S): No decline in sperm density was revealed in semen collected by men presenting for an initial screening semen analysis.

Entities:  

Mesh:

Year:  2000        PMID: 10689019     DOI: 10.1016/s0015-0282(99)00591-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

Review 1.  Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.

Authors:  Andras Perl; Robert Hanczko; Tiffany Telarico; Zachary Oaks; Steve Landas
Journal:  Trends Mol Med       Date:  2011-03-02       Impact factor: 11.951

Review 2.  Trends in global semen parameter values.

Authors:  Harry Fisch; Stephen R Braun
Journal:  Asian J Androl       Date:  2013-01-07       Impact factor: 3.285

Review 3.  The silent spermatozoon: are man-made endocrine disruptors killing male fertility?

Authors:  Bradley D Anawalt
Journal:  Asian J Androl       Date:  2013-01-21       Impact factor: 3.285

Review 4.  The Disappearing Sperms: Analysis of Reports Published Between 1980 and 2015.

Authors:  Pallav Sengupta; Sulagna Dutta; Elzbieta Krajewska-Kulak
Journal:  Am J Mens Health       Date:  2016-04-19

5.  Repeated assessment by high-throughput assay demonstrates that sperm DNA methylation levels are highly reproducible.

Authors:  Victoria K Cortessis; Kimberly Siegmund; Sahar Houshdaran; Peter W Laird; Rebecca Z Sokol
Journal:  Fertil Steril       Date:  2011-10-26       Impact factor: 7.329

6.  Transaldolase is essential for maintenance of the mitochondrial transmembrane potential and fertility of spermatozoa.

Authors:  Andras Perl; Yueming Qian; Kazim R Chohan; Cynthia R Shirley; Wendy Amidon; Sanjay Banerjee; Frank A Middleton; Karina L Conkrite; Maureen Barcza; Nick Gonchoroff; Susan S Suarez; Katalin Banki
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

7.  Asthenozoospermia in mice with targeted deletion of the sperm mitochondrion-associated cysteine-rich protein (Smcp) gene.

Authors:  Karim Nayernia; Ibrahim M Adham; Elke Burkhardt-Göttges; Jürgen Neesen; Mandy Rieche; Stephan Wolf; Ulrich Sancken; Kenneth Kleene; Wolfgang Engel
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 8.  Emerging technologies for home-based semen analysis.

Authors:  S Yu; M Rubin; S Geevarughese; J S Pino; H F Rodriguez; W Asghar
Journal:  Andrology       Date:  2017-12-01       Impact factor: 3.842

9.  Exposure to environmental ozone alters semen quality.

Authors:  Rebecca Z Sokol; Peter Kraft; Ian M Fowler; Rizvan Mamet; Elizabeth Kim; Kiros T Berhane
Journal:  Environ Health Perspect       Date:  2006-03       Impact factor: 9.031

10.  Widespread epigenetic abnormalities suggest a broad DNA methylation erasure defect in abnormal human sperm.

Authors:  Sahar Houshdaran; Victoria K Cortessis; Kimberly Siegmund; Allen Yang; Peter W Laird; Rebecca Z Sokol
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.